3.0.0 4395 2023-01-13T04:49:39Z 2023-01-13T04:49:39Z House H HR 2005-11-18 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-12-16T20:54:18Z Referred to 2005-11-18T14:03:25Z hswm00 Ways and Means Committee House Standing Referred to 2005-11-18T14:03:30Z 2005-12-16 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-11-18 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2005-11-18 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2005-11-18 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-11-18 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-11-18 Introduced in House IntroReferral 1000 9 Library of Congress C000714 Rep. Conyers, John, Jr. [D-MI-14] JOHN CONYERS D MI 14 N O000159 Rep. Owens, Major R. [D-NY-11] MAJOR OWENS D NY R. 11 2006-01-31 False H000636 Rep. Hinojosa, Ruben [D-TX-15] RUBEN HINOJOSA D TX 15 2006-01-31 False L000551 Rep. Lee, Barbara [D-CA-9] BARBARA LEE D CA 9 2006-01-31 False M000590 Rep. McNulty, Michael R. [D-NY-21] MICHAEL MCNULTY D NY R. 21 2006-02-07 False W000738 Rep. Woolsey, Lynn C. [D-CA-6] LYNN WOOLSEY D CA 6 2006-02-07 False Health Access to health care Administrative fees Administrative procedure Antibiotics Business records Coinsurance Commerce Compensation (Law) Congress Congressional reporting requirements Consumer discounts Cost control Cost effectiveness Department of Health and Human Services Drug advertising Drug industry Drug interactions Drugs Economics and Public Finance Electronic funds transfers Employee health benefits Federal advisory bodies Finance and Financial Sector Foreign Trade and International Finance Generic drugs Government Operations and Politics Government paperwork Government publications Government publicity Government trust funds Grievance procedures Health counseling Health insurance continuation Health maintenance organizations Housing and Community Development Import restrictions Imports Insurance premiums Intellectual property Labeling Labor and Employment Law Managed care Marketing Medicaid Medical economics Medical fees Medical records Medical savings accounts Medicare Medicare Payment Advisory Commission Medigap Packaging Patents Performance measurement Pharmaceutical research Pharmacies Pharmacists Physicians Prescription pricing Privatization Product counterfeiting Public service advertising Quality of care Research and development Retiree health benefits Rural health Science, Technology, Communications Social Welfare Standards State laws Subsidies Health 00 2005-11-18 Introduced in House 2005-12-20T16:44:14Z Medicare Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to revise part D (Voluntary Prescription Drug Benefit Program) as added by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to provide for: (1) no premium; (2) no deductible; (3) coinsurance at a rate of 10%; (4) a $1,500 annual limit on out-of-pocket spending on covered drugs; and (5) reduced cost-sharing for lower-income individuals.

Revises the Medigap program and the membership and duties of the Medicare payment advisory commission.

Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug and Cosmetic Act to: (1) repeal certain sections of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 relating to importation of prescription drugs from Canada; and (2) restore previous law, amended to direct the Secretary of Health and Human Services to allow qualifying individuals (in addition to pharmacists and wholesalers) to import covered products.

Repeals the mandate that the Secretary require a foreign seller to specify the original source of the product and the amount of each product lot originally received.

Amends requirements for the testing of imported covered products.

Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.

Establishes a permanent bipartisan Quality Control and Cost Containment Blue Ribbon Task Force.

Repeals the Comparative Cost Adjustment Program and prohibits the application of law in a manner that prevents a Medicare beneficiary from continuing to obtain benefits under a traditional fee-for-service Medicare program.

Amends SSA title XVIII to repeal the Medicare Advantage Regional Plan Stabilization Fund.

Repeals Health Savings Accounts.

Provides for application of risk adjustment reflecting characteristics for the entire Medicare population.

Directs the Secretary to make a specified phased-in adjustment of payment rates to Medicare+Choice payment organizations.

Repeals the Medicare expenditure cap.

Provides for continuous open enrollment in Medicare Advantage Plans.

]]> Medicare Prescription Drug Affordability Act of 2005 Display Title Medicare Prescription Drug Affordability Act of 2005 Official Title as Introduced To amend titles XVIII and XIX of the Social Security Act to provide for an improved voluntary Medicare prescription drug benefit, to provide greater access to affordable pharmaceuticals, and for other purposes. Introduced in House IH Short Titles as Introduced Medicare Prescription Drug Affordability Act of 2005 Short Titles as Introduced for portions of this bill Pharmaceutical Market Access Act of 2005 Introduced in House 2005-11-18T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr4395ih/xml/BILLS-109hr4395ih.xml 2005-12-16 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.